Astragalus injection ameliorates lipopolysaccharide-induced cognitive decline via relieving acute neuroinflammation and BBB damage and upregulating the BDNF-CREB pathway in mice | Synapse
May 19, 2022Open Access
Astragalus injection ameliorates lipopolysaccharide-induced cognitive decline via relieving acute neuroinflammation and BBB damage and upregulating the BDNF-CREB pathway in mice
Key Points
Key points are not available for this paper at this time.
Abstract
Astragalus injection could be a potential preventive and therapeutic strategy for sepsis survivors in clinical settings.